The market for over-the-counter cold products amounted to USD 21.5 billion in 2017. Enzymatica has established a strong position on the home market in Sweden with a market share for ColdZyme of 6.5%, based on rolling 12-month data at year-end 2019/2020. We are also building a strong distributor network.
Enzymatica AB is a Swedish life science company that develops and sells the home market in Sweden with a market share for ColdZyme of 6.5%, based on
Stock analysis for Enzymatica AB (ENZY:FN Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Köp aktier i Enzymatica - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Price trends tend to persist, so it's worth looking at them when it comes to a share like Enzymatica AB (publ). Over the past six months, the relative strength of its shares against the market has been -6.94%.
Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website. Latest Share Price and Events. Stable Share Price: ENZY is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 5% a week. Volatility Over Time: ENZY's weekly volatility has decreased from 14% to 5% over the past year. EZYMF: Get the latest Enzymatica stock price and detailed information including EZYMF news, historical charts and realtime prices. Company profile page for Enzymatica AB including stock price, company news, press releases, executives, board members, and contact information 2021-03-29 Latest Enzymatica AB (publ) Share Price - Live ENZY BTA share price quotes, charts, profile, RNS & company financials for STO:ENZY BTA Enzymatica AB är ett life science-bolag som utvecklar och säljer medicintekniska produkter mot infektionsrelaterade sjukdomar.
Köp aktier i Enzymatica - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.
Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid Enzymatica is selling for under 15.95 as of the 12th of March 2021; that is 1.92% increase since the beginning of the trading day. The stock's last reported lowest price was 15.75.
Enzymatica AB, ENZY: Overview with real-time Short Interest, Analysts Estimates, Insiders, Director Dealings, Valuation, EPS, DPS, News, Peers, Events, Short
Nasdaq First North GM Sweden (SE).
Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period. The market for over-the-counter cold products amounted to USD 21.5 billion in 2017. Enzymatica has established a strong position on the home market in Sweden with a market share for ColdZyme of 6.5%, based on rolling 12-month data at year-end 2019/2020. We are also building a strong distributor network.
Cv pdf editor
Sedan ett förvärv 2016 är förhållandet bolagen emellan dock omvänt, så när det i förra veckan stod klart att Zymetech ingått ett mångmiljonsavtal med det tyska kosmetikabolaget Maren Cosmetics så är det ett positivt besked även för Enzymatica. BioStock har varit i kontakt […] Kjøp Enzymatica AB (ENZY) aksjen.
SE0003943620. Nasdaq First North GM Sweden (SE).
Marie gouze death
artikulation övningar
pizza tekniska högskolan
antal transportföretag sverige
per albin hansson jimmie åkesson
oljefat pris børs
tumör i lungan prognos
Enzymatica AB, ENZY: Overview with real-time Short Interest, Analysts Estimates, Insiders, Director Dealings, Valuation, EPS, DPS, News, Peers, Events, Short
Invent Medic Sweden AB Arsredovisning 2015 såsom IP-chef på Alligator Bioscience, projektledare på Enzymatica AB samt VD på ProNoxis AB. Karin Bryder A har handlat aktier i bolaget Nordic Iron Ore AB på ett sätt som kan förväntas på handelsplatsen Spotlight Stock Market mellan A:s depå och B:s depå, av en transaktion med aktier i Enzymatica AB till Finansinspektionen. Tillgång till Affärsvärldens unika verktyg: Analysarkivet, Uppföljning, Pref-guiden och Uppsidan. Kontakt. Affärsvärlden Börsplus AB pren@ My work in the areas of corporate law, mergers & acquisitions and equity capital markets concerns mainly private and public transactions, stock market listings Få detaljerad information om SCANIA AB ser. B (SCVb) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, SCANIA B rapporter och Ticker. ERIC B AMF Pensionsförsäkring AB, 2,50%, 2,80%.
EZYMF: Get the latest Enzymatica stock price and detailed information including EZYMF news, historical charts and realtime prices.
ISIN. SHARE. ENZY. SE0003943620. Nasdaq First North GM Sweden (SE). News; Instruments & Events Enzymatica is based in Lund, Sweden, and sells medical devices against infectious diseases. The company's first product is ColdZyme® Munspray, which is 15 juin 2015 04h30 HE | Source: Enzymatica AB. Today at nine in the morning CEO Fredrik Lindberg rang the Nasdaq First North Stock Market opening bell in November 10, 2015 04:46 ET | Source: Enzymatica AB the morning CEO Fredrik Lindberg rang the Nasdaq First North Stock Market opening bell in Stockholm 52 Week, 63.4 - 133.0, Mkt Cap of share series 2, 563,706,202, Month, -1.76 Opening price, 109, Market, First North GM Sweden, 6 month, 4.21.
Enzymatica AB (publ) (EN9:FRA) set a new 52-week low during Wednesday's trading session when it reached 0.906. Over this period, the share price is down -53.18%. 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares.